FDA Inspection 1175105 — Cliantha Research Ltd
The FDA completed an inspection of Cliantha Research Ltd on July 8, 2022 in Vadodara. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 8, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vadodara (India)
Additional Details
Clinical BA/BE